132 related articles for article (PubMed ID: 37225016)
1. Enhancing de novo ceramide synthesis induced by bisphenol A exposure aggravates metabolic derangement during obesity.
Wang G; Hong X; Yu J; Zhang Y; Li Y; Li Z; Zhu Z; Yuan S; Zhang X; Wang S; Zhu F; Wang Y; Wu C; Su P; Shen T
Mol Metab; 2023 Jul; 73():101741. PubMed ID: 37225016
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats.
Campana M; Bellini L; Rouch C; Rachdi L; Coant N; Butin N; Bandet CL; Philippe E; Meneyrol K; Kassis N; Dairou J; Hajduch E; Colsch B; Magnan C; Le Stunff H
Mol Metab; 2018 Feb; 8():23-36. PubMed ID: 29233519
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity.
Camell CD; Nguyen KY; Jurczak MJ; Christian BE; Shulman GI; Shadel GS; Dixit VD
J Biol Chem; 2015 Dec; 290(49):29402-13. PubMed ID: 26438821
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
Ussher JR; Koves TR; Cadete VJ; Zhang L; Jaswal JS; Swyrd SJ; Lopaschuk DG; Proctor SD; Keung W; Muoio DM; Lopaschuk GD
Diabetes; 2010 Oct; 59(10):2453-64. PubMed ID: 20522596
[TBL] [Abstract][Full Text] [Related]
5. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Ceramide De Novo Synthesis Affects Adipocytokine Secretion and Improves Systemic and Adipose Tissue Insulin Sensitivity.
Blachnio-Zabielska AU; Hady HR; Markowski AR; Kurianiuk A; Karwowska A; Górski J; Zabielski P
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545025
[TBL] [Abstract][Full Text] [Related]
7. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
8. Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity.
Bielawiec P; Harasim-Symbor E; Konstantynowicz-Nowicka K; Sztolsztener K; Chabowski A
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32859125
[TBL] [Abstract][Full Text] [Related]
9. Environmental endocrine disruptor Bisphenol A induces metabolic derailment and obesity via upregulating IL-17A in adipocytes.
Hong X; Zhou Y; Zhu Z; Li Y; Li Z; Zhang Y; Hu X; Zhu F; Wang Y; Fang M; Huang Y; Shen T
Environ Int; 2023 Feb; 172():107759. PubMed ID: 36696794
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance.
Ussher JR; Folmes CD; Keung W; Fillmore N; Jaswal JS; Cadete VJ; Beker DL; Lam VH; Zhang L; Lopaschuk GD
PLoS One; 2012; 7(5):e37703. PubMed ID: 22629445
[TBL] [Abstract][Full Text] [Related]
12. Cigarette smoke exposure impairs β-cell function through activation of oxidative stress and ceramide accumulation.
Tong X; Chaudhry Z; Lee CC; Bone RN; Kanojia S; Maddatu J; Sohn P; Weaver SA; Robertson MA; Petrache I; Evans-Molina C; Kono T
Mol Metab; 2020 Jul; 37():100975. PubMed ID: 32283079
[TBL] [Abstract][Full Text] [Related]
13. Adipocyte mTORC1 deficiency promotes adipose tissue inflammation and NLRP3 inflammasome activation via oxidative stress and de novo ceramide synthesis.
Chimin P; Andrade ML; Belchior T; Paschoal VA; Magdalon J; Yamashita AS; Castro É; Castoldi A; Chaves-Filho AB; Yoshinaga MY; Miyamoto S; Câmara NO; Festuccia WT
J Lipid Res; 2017 Sep; 58(9):1797-1807. PubMed ID: 28679588
[TBL] [Abstract][Full Text] [Related]
14. The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver.
Jani S; Da Eira D; Stefanovic M; Ceddia RB
J Physiol; 2022 Sep; 600(18):4137-4151. PubMed ID: 35974660
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population.
Chathoth S; Ismail MH; Alghamdi HM; Zakaria HM; Hassan KA; Alshomimi S; Vatte C; Cyrus C; Alsaif HS; Mostafa A; Shaaban H; Al Ali A
Lipids Health Dis; 2022 Feb; 21(1):24. PubMed ID: 35184720
[TBL] [Abstract][Full Text] [Related]
18. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.
Shah C; Yang G; Lee I; Bielawski J; Hannun YA; Samad F
J Biol Chem; 2008 May; 283(20):13538-48. PubMed ID: 18359942
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.
Fillmore N; Keung W; Kelly SE; Proctor SD; Lopaschuk GD; Ussher JR
Exp Physiol; 2015 Jun; 100(6):730-41. PubMed ID: 25786668
[TBL] [Abstract][Full Text] [Related]
20. Ceramides mediate cigarette smoke-induced metabolic disruption in mice.
Thatcher MO; Tippetts TS; Nelson MB; Swensen AC; Winden DR; Hansen ME; Anderson MC; Johnson IE; Porter JP; Reynolds PR; Bikman BT
Am J Physiol Endocrinol Metab; 2014 Nov; 307(10):E919-27. PubMed ID: 25269485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
